Screening compound: C28H35N5O3 (L610-0442)

Screening compound: C<sub>28</sub>H<sub>35</sub>N<sub>5</sub>O<sub>3</sub> (L610-0442)
Screening compound: C<sub>28</sub>H<sub>35</sub>N<sub>5</sub>O<sub>3</sub> (L610-0442) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C28H35N5O3 (L610-0442)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L610-0442

Molecular Formula

C28H35N5O3 (C28 H35 N5 O3)

Compound Name

2-{[5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]methyl}-N~1~-[3-(4-methylpiperazino)propyl]benzamide

IUPAC name

2-({28-dioxo-39-diazatricyclo[8.4.0.0^{37}]tetradeca-1(14)1012-trien-9-yl}methyl)-N-[3-(4-methylpiperazin-1-yl)propyl]benzamide

SMILES

CN1CCN(CCCNC(c2c(CN(c(cccc3)c3C(N3C4CCC3)=O)C4=O)cccc2)=O)CC1

InChI

InChI=1S/C28H35N5O3/c1-30-16-18-31(19-17-30)14-7-13-29-26(34)22-9-3-2-8-21(22)20-33-24-11-5-4-10-23(24)27(35)32-15-6-12-25(32)28(33)36/h2-5,8-11,25H,6-7,12-20H2,1H3,(H,29,34)/t25-/m0/s1

InChI Key

FAUJKDGLCZEFDU-VWLOTQADSA-N

MDL Number (MFCD)

MFCD27465887

C28H35N5O3 (L610-0442) in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Epigenetics Focused Set (26518 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with C28H35N5O3 (L610-0442) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C28H35N5O3 (L610-0442)?
Check Price and Availability of C28H35N5O3 (L610-0442), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C28H35N5O3 (L610-0442) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C28H35N5O3 (L610-0442)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C28H35N5O3 (L610-0442)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C28H35N5O3 (L610-0442) available by request